Summary
AstraZeneca UK Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc is a biotechnology company that offers asthma treatment solutions. The company offers research, discovery and development services for various novel and targeted therapies. It offers its services in therapeutic areas such as cardiovascular; oncology, respiratory, inflammation and autoimmunity; neuroscience and infection and vaccines. The company’s targeted therapies provide treatment of cardiovascular and metabolic diseases; oncology diseases; respiratory diseases, inflammations; infections and other neuroscience diseases. It has its operations in Angola, Botswana, Ghana, Lesotho, Germany, Argentina, Brazil, Canada, Chile, Colombia, India, Japan, China, Norway, Russia, the UAE, the UK and the US, among others. AstraZeneca is headquartered in London, the UK.
AstraZeneca UK Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Bind Therapeutics Enters Into Co-Development Agreement With AstraZeneca For Accurin 10
Asset Transactions 11
Alliance Pharma Acquires Antimalarial Drug Brands From AstraZeneca UK For US$8 Million 11
Acquisition 12
AstraZeneca Completes Acquisition Of Remaining 20% Stake In AstraZeneca K.K. From Sumitomo Chemical For US$102 Million 12
AstraZeneca UK Ltd - Key Competitors 14
Key Employees 15
Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17
List of Tables
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Key Facts, 2015 1
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AstraZeneca UK Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Bind Therapeutics Enters Into Co-Development Agreement With AstraZeneca For Accurin 10
Alliance Pharma Acquires Antimalarial Drug Brands From AstraZeneca UK For US$8 Million 11
AstraZeneca Completes Acquisition Of Remaining 20% Stake In AstraZeneca K.K. From Sumitomo Chemical For US$102 Million 12
AstraZeneca UK Ltd, Key Competitors 14
AstraZeneca UK Ltd, Key Employees 15
List of Figures
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8